Morphological and Proliferative Responses of Rat Microglia Cells to Lipopolysaccharide and Β-Amyloid by Badiei, Alireza
  
 
UNIVERSITI PUTRA MALAYSIA 
 
 
 
Morphological and Proliferative Responses of Rat Microglia Cells to 
Lipopolysaccharide and β-Amyloid  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ALIREZA BADIEI 
 
 FPV 2008 9 
 
 
 
 
Morphological and Proliferative Responses of Rat 
Microglia Cells to Lipopolysaccharide and β-
Amyloid 
 
 
 
 
 
 
 
 
ALIREZA BADIEI 
 
 
 
 
 
 
 
 
 
Master of Science 
Universiti Putra Malaysia 
 
November 2008 
  
ii
Abstract of thesis presented to the Senate of Universiti Putra Malaysia in 
fulfilment of the requirement for the degree of Master of Science 
 
MORPHOLOGICAL AND PROLIFERATIVE RESPONSES OF RAT 
MICROGLIAL CELLS TO LIPOPOLYSACCHARIDE AND BETA AMYLOID 
 
By 
ALIREZA BADIEI 
June 2008 
 
Chairman : Sharmili Vidyadaran, PhD 
Faculty : Faculty of Medicine and Health Sciences 
 
Microglia are the residential macrophages of the central nervous system 
(CNS) and are sensitive to any changes in their environment. There is rapid 
microglial activation in most pathological conditions in CNS. The association 
of activated microglia with various inflammatory and neurodegenerative 
diseases are well documented. In this study we evaluated the in vitro 
responses of microglia to lipopolysaccharide (LPS) or beta amyloid (Aβ) in an 
attempt to further define the activation of microglia. LPS is a potent activator 
of monocytes and macrophages and Aβ is used to activate microglia in vitro 
into a neurotoxic phenotype distinguished by secretion of proinflammatory 
molecules. Microglia were cultured from Sprague-Dawley neonatal rats and 
purity of culture determined using a common marker for microglia, lectin. 
Morphological changes following LPS or Aβ treatment were evaluated using 
fluorescent and confocal microscope. Treated microglia assumed a 
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deramified shape with a condensed cytoplasm, typical of activated microglia. 
Stimulation of microglia with LPS or Aβ also resulted in significant 
ultrastructural changes. Transmission electron microscopy revealed an 
increased number of enlarged, elongated and swollen mitochondria. There 
were also some changes in the appearance of the endoplasmic reticulum. 
Untreated microglia displayed mainly smooth endoplasmic reticulum (SER) 
whereas LPS-treated cells displayed polyribosomes and rough endoplasmic 
reticulum (RER). It is therefore assumed that LPS-treated microglia have an 
increased ability in synthesising protein, some of which may be secretory 
molecules necessary for inflammation. Aβ-treated microglia also displayed 
more RER compared to control, but lesser compared to LPS. The nucleus in 
treated microglia appeared enlarged in comparison to untreated cells. The 
number of cells following treatment revealed that microglia are more viable 
following LPS treatment compared to Aβ. Immunophenotyping assays 
demonstrated upregulation of MHC II and CD40 by microglia following 
treatment. Both MHC II and CD40 are implicated in antigen-presenting and 
this result indicates that in comparison to LPS, Aβ may have more ability to 
induce antigen-presenting capabilities in microglia. As shown by viability 
counts, carboxy fluorescein succinimidyl ester (CFSE) staining also revealed 
no microglia proliferation following treatment with LPS and Aβ. In conclusion, 
our study illustrates activation-induced alterations in the morphology, 
ultrastructure and cell surface phenotype of microglia, which were not 
accompanied by proliferation of microglia. These changes represent the 
range of effects that occur in microglia following activation. In an attempt to 
culture microglia from adult rats for the purpose of determining the effects of 
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aging on microglia responses, modifications were made on the established 
protocol for neonatal microglia cultures. This includes growing adult cells on 
poly-L-lysine-coated tissue culture flasks and substituting insulin in cell 
culture media with insulin-transferrin-selenium (ITS). We were able to 
successfully support the in vitro growth of adult microglia, which was also 
enhanced with the addition of the growth factor M-CSF. 
 
Key words: microglia, lipopolysacharide, beta amyloid, morphology, 
proliferation, CD40/MHC II 
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Mikroglia merupakan makrofaj residen dalam sistem saraf pusat. Mikroglia 
dirangsang dengan cepat dalam kebanyakan keadaan patologi. Banyak 
penulisan saintifik yang membuktikan hubungan di antara mikroglia dengan 
inflamasi dan penyakit neurodegenerasi. Dalam kajian ini, kami menilai 
gerakbalas mikiroglia ke atas rawatan dengan lipopolysaccharide (LPS) dan 
beta amyloid (Aβ) secara in vitro untuk mengenalpasti cara pengaktifan 
mikroglia dengan lebih lanjut lagi. Mikroglia dikultur daripada tikus neonat 
Sprague- Dawley dan tahap ketulenan kultur ditentukan melalui lektin yang 
merupakan satu molekul penunjuk umum pada sel mikroglial. Perubahan 
morfologi mikroglia selepas rawatan dengan LPS dan Aβ ditentukan dengan 
menggunakan mikroskop fluoresen dan konfokal. Mikroglia yang dirawat 
dikenal sebagai sel yang kurang bercabang (deramified) dengan sitoplasma 
yang kondens. Ini adalah keadaan lazim bagi sel mikroglia yang telah 
menjadi aktif. Rangsangan dengan LPS dan Aβ juga menyebabkan 
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perubahan ultra-struktur dan rupabentuk yang ketara. Mikroskop elektron 
transmisi menunjukkan penambahan bilangan mitokondria yang 
membengkak, memanjang dan membesar. Terdapat juga perubahan 
rupabentuk pada reticulum endoplasma. Sel mikroglia yang tidak menerima 
sebarang rawatan mempunyai kebanyakannya retikulum endoplama yang 
licin (smooth endoplasmic reticulum, SER) dan apabila dirawat dengan LPS, 
sel-sel mempamerkan poliribisom (polyribosome) dan reticulum endoplasma 
kasar (rough reticulum endoplasmic, RER). Sel yang dirawat dengan Aβ juga 
mempamerkan lebih banyak reticulum endoplasma kasar berbanding dengan 
sel kawalan. Akhirnya, sel yang dirawat juga mempamerkan pembesaran 
nukleus berbanding dengan sel yang tidak dirawat. Asei 
“immunophenotyping” menunjukkan penambahan ekpresi molekul MHC 
kelas dua dan CD40 pada permukan sel mikroglial sejurus menerima 
rawatan. Tiada proliferasi diperhatikan selepas rawatan sel dengan LPS dan 
Aβ, seperti yang telah ditunjukan melalui pewarnaan CSFE. Ringkasnya, 
kajian kami telah menunjukkan perubahan ultrastruktur dan rupabentuk serta 
“fenotip” permukaan sel-sel mikroglial sejurus selepas sel-sel tersebut 
dirangsang. Perubahan-perubahan ini bukanlah disebabkan proliferasi sel. 
Semua perubahan ini mewakili pelbagai easan yang terjadi kepada sel 
mikroglial selepas diaktifkan. Untuk pengkulturan sel mikroglia dewasa bagi 
tujuan kajian ke atas kesan penuaan kepada mikroglia, beberapa modifikasi 
telah dijalankan kepada protokol pengkulturan mikroglia daripada tikus muda. 
Pada amnya, ini termasuk pengkulturan mikroglia dewasa di dalam kelalang 
kultur tisu yang terlebih dahulu disaluti dengan poly-L-lysine dan 
menggantikan insulin di dalam media kultur sel dengan insulin-transferrin-
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selenium (ITS). Kami berjaya mengkultur sel mikroglia dewasa, dan ini 
dibaiki lagi dengan penambahan faktor pertumbuhan, M-CSF. 
 
Kata kunci: mikroglia, lipopolisakarida, amyloid  beta, morfologi, proliferasi, 
CD40/MHC II 
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CHAPTER 1 
INTRODUCTION 
1.1. Background 
 
Microglia are the residential macrophages of the central nervous system 
(CNS). Their immunological roles include phagocytosis of invading 
microorganisms and removal of dead cells within the CNS. In the normal 
CNS, microglia are in a resting state, however they quickly become activated 
following any stress or injury to the CNS.  
 
Ramified microglia, represent the resting state of the cells, are found 
throughout the healthy CNS. They are composed of long branching 
processes and a small cellular body. While the branches of resting ramified 
microglia are constantly moving and surveying the surrounding area, the cell 
body remains fairly motionless. The branches are very sensitive to small 
changes in physiological condition. Unlike activated or amoeboid microglia, 
ramified microglia are unable to phagocytose cells (Aloisi, 2001; Christensen 
et al., 2006). In addition to being very sensitive to small changes in their 
environment, each microglial cell also physically surveys its domain on a 
regular basis. While moving through CNS regions, the microglial cell 
scavenges for foreign material, damaged cells, apoptotic cells, neural 
tangles, DNA fragments, or plaques. It will then become activated and 
phagocytose the material or launch inflammation if necessary. In this manner 
microglial cells also act as “housekeepers”, cleaning up random cellular 
debris (Aloisi, 2001).  
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Following activation, microglia proliferate, express MHC class I and II 
antigens, cell adhesion molecules, release inflammatory cytokines and 
become phagocytotic cells (Gehrmann et al., 1995). Injury to neurones leads 
to activation of microglia, which causes cellular hypertrophy, decrease in 
ramification and cellular proliferation (Olesen et al., 2007). 
 
It is believed that hyperactivation of microglia may however be counter-
productive in its effort to limit CNS damage. Activated microglia is detected 
brains of patients with Alzheimer’s disease (AD) and Parkinson’s disease 
(PD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), human 
immunodeficiency virus (HIV) infection, and prion-related diseases (Liu & 
Hong, 2003). Previously, the inflammatory activities of microglia were 
conceived as only a reactive response to neuronal damage. However, 
increasing reports demonstrate that inflammatory activities of microglia 
worsen neuronal damage, which then fuels a self-propelling cycle of neuronal 
death. Proinflammatory mediators such as the cytokines IL-6, IL-1β, and 
TNF-α are secreted by activated microglia and can induce cell death in 
neurodegeneration (Glezer et al., 2007). Thus, while the triggers of various 
neurodegenerative diseases are different, inflammation may be a basic 
mechanism driving the progressive nature of these diseases. Although 
astrocytes and infiltrating lymphocytes have also been listed as contributors 
to inflammation-mediated neurodegeneration, microglia are concerned as 
critical components of neuroinflammation (Aloisi et al., 1998; Stoll & Jander, 
1999; Miljkovic et al., 2007). 
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It is of great scientific benefit to further study the process of microglia 
activation and its role in degeneration. Limiting the inflammatory actions of 
microglia may prove to be a suitable therapeutic approach for 
neurodegenerative and neuroinflammatory diseases. In this study in vitro 
responses of microglia to two activators, LPS or Aβ were determined. 
Although in vivo studies are equally important for dissecting the mechanisms 
of microglia activation, in vitro systems have the advantage of being a more 
controlled environment for the study of cell form and function.  
 
Microglia were cultured from neonatal rats and activated with 
lipopolysaccharide (LPS) or the active fragment of beta-amyloid (Aβ). LPS is 
commonly used to induce microglia activation both in vitro and in vivo and Aβ 
is the misfolded protein found in senile plaques of AD patients. Morphological 
changes to microglia following activation include deramification, with 
microglia assuming an amoeboidal shape with a condensed cytoplasm. We 
further explored morphological changes by examining changes at the 
ultrastructure level. Stimulation of monocytes and macrophages by LPS is 
reported (Meng & Lowell, 1997) and Aβ is used to activate microglia in vitro 
into a neurotoxic phenotype distinguished by secretion of excess of 
proinflammatory molecules (Floden et al., 2005). 
 
We also investigated whether activation of microglia affects expression of the 
cell surface molecules, MHC II and CD40. MHC II is expressed on antigen 
presenting cells and is reportedly upregulated following microglia activation. 
CD40 is a co-stimulatory molecule required for microglia activation, shown to 
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be upregulated in IFN-γ-activated microglia (Nguyen et al., 1998). Strategies 
to attenuate microglia inflammatory responses by inhibiting the activation of 
microglia (by suppression of CD40 expression) may be of benefit for several 
neuroinflammatory diseases. 
 
In vivo studies suggest that microglia number expand following insult via (i) 
resident microglia division, and/or (ii) recruitment of circulating monocytes 
and differentiation to microglia (Lawson et al., 1992; Streit, 2006; Remington 
et al., 2007). Details of this proliferation wave in activated microglia are 
limited. In this study, we will evaluate the in vitro proliferation cycle of 
microglia following treatment with LPS or Aβ.  
 
Majority of in vitro studies utilise microglia isolated from neonatal rodents, as 
these cells have high proliferative capacity in culture. However, as neonatal 
microglia are expected to respond differently from adult microglial cells 
(Conde & Streit, 2006), the need for a suitable culture system for adult 
microglia is also apparent. It is assumed that neonatal microglial cells are 
functionally immature. Compared to the amoeboidal neonatal microglia, adult 
microglia demonstrate a ramified morphology. Several studies have used ex 
vivo isolated adult microglia to scrutinise the activities of these cells. The 
difficulty with using adult microglial cells that have been isolated ex vivo is 
their affinity to undergo cell death a few days after culture. 
 
